Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

A new patch can deliver stable antibodies over time for potential HIV treatment.

The M5 method is best for isolating cells that help hair growth.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

A hormone affects hair growth, certain molecules may prevent skin damage, a skin disease is linked to immune cells, glycerol helps skin hydration, and psoriasis treatment trials need improvement.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

ALEP is a drug-triggered skin reaction with pustules that clears up in a week after stopping the drug.

A new AIRE gene mutation causes rare autoimmune symptoms in a Lebanese boy.

Early intervention and protective measures are crucial for managing CIPA due to the lack of pain and standard treatment.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Peanut stem extract has strong antioxidants and moderate cancer-fighting potential.

PLX, a tomato extract mix, may help treat prostate issues like BPH.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

An AI device for skin cancer was successfully integrated into the NHS, improving diagnosis accuracy and service capacity.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

p2y5, now called LPA6, is a receptor important for human hair growth.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

PCE-DP brightens skin and promotes hair growth by enhancing cell growth and reducing melanin uptake.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.